COCPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Cocrystal Pharma, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.95−0.07 (-7.20%)
Close on Oct 19, 2026
- Market cap
- $13.05M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Aug 14, 2023(first seen in filings) | 1-for-12 reverse | Earlier per-share figures multiplied by 12 |
| Oct 11, 2022 | 1-for-12 reverse | Earlier per-share figures multiplied by 12 |
| Mar 21, 2018(first seen in filings) | 1-for-30 reverse | Earlier per-share figures multiplied by 30 |
| Jan 24, 2018 | 1-for-30 reverse | Earlier per-share figures multiplied by 30 |
| Aug 14, 2014(first seen in filings) | 100-for-1 | Earlier per-share figures divided by 100 |